Login / Signup

Montelukast drug activity and potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Dennis C CopertinoRodrigo R R DuarteTimothy R PowellMiguel de MulderDouglas F Nixon
Published in: Journal of medical virology (2020)
Keyphrases
  • respiratory syndrome coronavirus
  • sars cov
  • coronavirus disease
  • human health
  • emergency department
  • adverse drug
  • climate change
  • risk assessment